# reload+after+2024-01-23 22:34:03.655551
address1§3838 West Parkway Boulevard
city§Salt Lake City
state§UT
zip§84120
country§United States
phone§801 954 7100
fax§801 954 7300
website§https://www.usana.com
industry§Packaged Foods
sector§Consumer Defensive
longBusinessSummary§USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
fullTimeEmployees§1900
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Kevin G. Guest', 'age': 60, 'title': 'Executive Chairman', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 1287124, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jim  Brown', 'age': 54, 'title': 'CEO & President', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 790561, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. G. Douglas Hekking', 'age': 53, 'title': 'Chief Financial Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 648806, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Walter  Noot', 'age': 57, 'title': 'Chief Operating Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 624562, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David  Mulham', 'age': 63, 'title': 'Chief Sales Officer', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 601721, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Myron W. Wentz', 'age': 82, 'title': 'Founder & Chairman Emeritus', 'yearBorn': 1941, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. John  Cuomo', 'title': 'Executive Director of Product Development & Technology', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Robert A. Sinnott M.N.S., Ph.D.', 'age': 58, 'title': 'Chief Scientific Officer', 'yearBorn': 1965, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Patrique  Richards', 'title': 'Executive Director of Investor Relations & Business Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. P. Joshua Foukas', 'age': 47, 'title': 'Chief Legal Officer, General Counsel & Corporate Secretary', 'yearBorn': 1976, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§6
boardRisk§6
compensationRisk§7
shareHolderRightsRisk§2
overallRisk§4
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.864
priceToSalesTrailing12Months§1.0434021
currency§USD
dateShortInterest§1702598400
forwardEps§2.91
pegRatio§1.17
exchange§NYQ
quoteType§EQUITY
shortName§USANA Health Sciences, Inc.
longName§USANA Health Sciences, Inc.
firstTradeDateEpochUtc§765466200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§e60428ae-057a-325e-b132-f070e079f759
gmtOffSetMilliseconds§-18000000
targetHighPrice§68.0
targetLowPrice§53.0
targetMeanPrice§60.5
targetMedianPrice§60.5
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§2
quickRatio§2.728
earningsGrowth§-0.241
grossMargins§0.80514
ebitdaMargins§0.11261
trailingPegRatio§1.3738
